Treatment of Borderline Personality Disorder and Medicinal Cannabis as an Alternative
According to the Brazilian Society of Psychology (SBP), BPD affects about 1% to 6% of the global population, being much more common in women.
Published on 01/02/2024

By Sechat editorial team
In White January, a month dedicated to raising awareness about mental health, we highlight the relevance of Borderline Personality Disorder (BPD), affecting about 6% of the global population, according to the Brazilian Psychiatric Association (ABP). In Brazil, approximately 10% of those diagnosed with BPD face the risk of suicide, highlighting the urgency to develop innovative therapeutic approaches.
BPD, characterized by emotional instability, impulsivity, and difficulty in relationships, presents complex challenges for patients and mental health professionals. Among the possible treatment alternatives is the use of cannabidiol (CBD), a compound derived from cannabis, which has shown benefits in controlling symptoms.
BPD is more prevalent in women, typically manifesting in late adolescence. It is characterized by significant mood instability, hypersensitivity, and conflictual relationship patterns, including self-destructive tendencies.

CBD, a component of cannabis, is one of the alternatives in treatment due to its neuroprotective and antipsychotic properties. Preclinical studies indicate that cannabinoids may attenuate neurodegeneration by reducing oxidative damage and excitotoxicity through CB1 and CB2 receptors.
In the treatment of BPD, CBD may play an important role in modulating the endocannabinoid system, contributing to mood stabilization and reduction of psychotic symptoms. CBD may also increase levels of anandamide, a substance related to mood control, offering an innovative therapeutic approach.
In addition to the potential benefits of CBD, it is important to emphasize that BPD, while without a definitive cure, can be managed with appropriate treatments. Cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT) are widely used to assist patients in managing emotions and behaviors.
Brazilian Congress on Medicinal Cannabis
The main congress of Latin America of a scientific and professional nature, which seeks to bring innovation and advances related to the medicinal use of cannabis.
Medications such as antidepressants, antipsychotics, and mood stabilizers are also prescribed by many doctors in the treatment of BPD. However, these allopathic medications can bring side effects such as gastrointestinal problems, headaches, lack of motor coordination, and changes in sleep and energy levels.
As awareness of BPD increases, new treatment possibilities arise, offering hope for those facing challenges related to this disorder.


